ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $13,190 | -90.7% | 12,101 | -84.5% | 0.00% | -100.0% |
Q3 2021 | $142,395 | +25.7% | 78,239 | +82.3% | 0.00% | 0.0% |
Q2 2021 | $113,304 | -63.1% | 42,918 | -49.7% | 0.00% | -66.7% |
Q1 2021 | $307,217 | +105.2% | 85,338 | +43.6% | 0.00% | +50.0% |
Q4 2020 | $149,718 | -10.7% | 59,412 | -10.7% | 0.00% | 0.0% |
Q3 2020 | $167,615 | -47.7% | 66,514 | -32.0% | 0.00% | -50.0% |
Q2 2020 | $320,689 | +55.2% | 97,771 | +16.0% | 0.00% | +33.3% |
Q1 2020 | $206,564 | -21.7% | 84,312 | +50.8% | 0.00% | 0.0% |
Q4 2019 | $263,900 | -17.8% | 55,911 | -25.4% | 0.00% | -25.0% |
Q3 2019 | $320,957 | -26.6% | 74,990 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $437,191 | +76.4% | 74,990 | +16.5% | 0.01% | +66.7% |
Q1 2019 | $247,855 | +105.9% | 64,378 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $120,387 | -41.6% | 64,378 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $206,010 | +3.5% | 64,378 | -2.4% | 0.00% | 0.0% |
Q2 2018 | $199,000 | +36.3% | 65,990 | +77.1% | 0.00% | 0.0% |
Q1 2018 | $146,000 | -42.5% | 37,256 | -39.3% | 0.00% | -33.3% |
Q4 2017 | $254,000 | – | 61,375 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |